Medical electronics equipment company Medtronic plc gets further close to developing an artificial pancreas by developing device which can deliver insulin based on the sugar levels in the blood using hyper closedloop feedback system. A device called MiniMed 640G system controls automatically the glucose levels in the diabetic patients 24 hours a day with less inputs from the diabetic patients. Medtronics has reported tests results from the European User Evaluation of the MiniMed 640G system, which demonstrated that the pump's exclusive SmartGuard technology can reduce hypoglycemia (low blood glucose). MiniMed 640G system uses new insulin pump With simple user interface, colour screen in a waterproofed unit.
The next step in artificial pancreas, Medtronics is developing is Hybrid Closed Loop system takes lesser inputs from patients to control glucose level 24 hours a day. The users need to re-enter their carbohydrates at mealtime and calibrated sensor periodically.
Medtronics and the samsung are partnering to make use of smart phones and mobile devices to keep the patient well-informed, both have agreed to develop a mobile health app for diabetic patients optimized for Samsung mobile devices that will enable the viewing of insulin pump and continuous glucose monitoring (CGM) information. This app works with Medtronic’s MiniMed. The mobile app provides access to glucose sugar levels to the people with diabetes and also to their loved ones, and is expected to be available in the United States later this year.
There are over 387 million people in the world with diabetes, according to the International Diabetes Federation (IDF). Medical electronics is leveraging mobile technology to makes things easy to manage diabetes.